Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 373-380

  Niccoli, Giampaolo ^a   Conte, Micaela ^a   Bona, Roberta Della ^a   Altamura, Luca ^a   Siviglia, Massimo ^a   Dato, Ilaria ^a   Ferrante, Giuseppe ^a   Leone, Antonio M ^a   Porto, Italo ^a   Burzotta, Francesco ^a   Brugaletta, Salvatore ^a   Biasucci, Luigi M ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atherosclerosis; Coronary angiography; Cystatin C

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MULTIVARIATE ANALYSIS; PHENOTYPE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEX DIFFERENCE; STANDARD; STATISTICAL SIGNIFICANCE; THORAX PAIN;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 43949116587     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.022     Document Type: Article

References (32)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
2. Levin A., and Cystatin C. Serum creatinine, and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk. Ann Intern Med 142 (2005) 586-588
3. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
4. Liu J., Sukhova G.K., Sun J.S., Xu W.H., Libby P., and Shi G.P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 1359-1366
5. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
6. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
7. Smith G.L., Lichtman J.H., Bracken M.B., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
8. Sarnak M.J., Katz R., Stehman-Breen C.O., et al. Cardiovascular health study. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142 (2005) 497-505
9. Jernberg T., Lindahl B., James S., Larsson A., Hansson L.O., and Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 110 (2004) 2342-2348
10. Ognibene A., Mannucci E., Caldini A., et al. Cystatin C reference values and aging. Clin Biochem 39 (2006) 658-661
11. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-Reactive Protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331 (1994) 417-425
12. Sullivan D.R., Marwick T.H., and Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119 (1990) 1262-1279
13. Kaski J.C., Chester M.R., Chen L., and Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 92 (1995) 2058-2065
14. Kaski J.C., Chen L., and Chester M. Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty. J Am Coll Cardiol 26 (1995) 416-421
15. Chen L., Chester M., Redwood S., Huang J., Leatham E., and Kaski J.C. Angiographic stenosis progression and coronary events in patients with "stabilised" unstable angina. Circulation 91 (1995) 2319-2324
16. Ambrose J.A., Winters S.L., Stern A., et al. Angiographic morphology and the pathogenesis of unstable angina. J Am Coll Cardiol 5 (1985) 609-616
17. Koenig W., Twardella D., Brenner H., and Rothenbacher D. Plasma concentrations of Cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51 (2005) 321-327
18. Bigi R., Cortigiani L., Colombo P., Desideri A., Bax J.J., and Parodi O. Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions. Heart 89 9 (2003) 1009-1013
19. Pucci L., Triscornia S., Lucchesi D., et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 53 (2007) 480-488
20. Rule A.D., Larson T.S., Bergstralh E.J., Slezak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 12 (2004) 929-937
21. Yerkey M.W., Kernis S.J., Franklin B.A., Sandberg K.R., and McCullough P.A. Renal dysfunction and acceleration of coronary disease. Heart 90 (2004) 961-966
22. Nicholls S.J., Tuzcu E.M., Crowe T., et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol 47 (2006) 1967-1975
23. Singh D., Whooley M.A., Ix J.H., Ali S., and Shlipak M.G. Association of cystatin C and estimated GFR with inflammatory biomarkers: the heart and soul study. Nephrol Dial Transplant 22 4 (2007) 1087-1092
24. Knight E.L., Verhave J.C., Spiegelmon D., et al. Factors influencing serum Cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004) 1416-1421
25. Niccoli G, Biasucci LM, Biscione C, et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2007; [Epub ahead of print].
26. Eriksson P., Deguchi H., Samnegard A., et al. Human evidence that the Cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 24 (2004) 551-557
27. Loew M., Hoffmann M.M., Koenig W., Brenner H., and Rothenbacher D. Genotype and plasma concentration of Cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol 25 (2005) 1470-1474
28. Ellis S., Alderman E., Cain K., Fisher L., Sanders W., and Bourassa M. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS registry study. J Am Coll Cardiol 11 5 (1988) 908-916
29. Jasir A., Kasprzykowski F., Kasprzykowska R., Lindstrom V., Schalen C., and Grubb A. New antimicrobial Cystatin C-based peptide active against gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci. APMIS 111 (2003) 1004-1010
30. Moreno P.R., Murcia A.M., Palacios I.F., et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102 (2000) 2180-2184
31. Burke A.P., Kolodgie F.D., Farb A., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103 (2001) 934-940
32. Gaspardone A., Crea F., Perino M., et al. Risk factors in patients with different clinical and angiographic manifestations of ischemic heart disease. Cardiologia 40 (1995) 679-684